281 related articles for article (PubMed ID: 19372586)
1. DNA-dependent protein kinase (DNA-PK)-dependent cisplatin-induced loss of nucleolar facilitator of chromatin transcription (FACT) and regulation of cisplatin sensitivity by DNA-PK and FACT.
Dejmek J; Iglehart JD; Lazaro JB
Mol Cancer Res; 2009 Apr; 7(4):581-91. PubMed ID: 19372586
[TBL] [Abstract][Full Text] [Related]
2. Concordant and opposite roles of DNA-PK and the "facilitator of chromatin transcription" (FACT) in DNA repair, apoptosis and necrosis after cisplatin.
Sand-Dejmek J; Adelmant G; Sobhian B; Calkins AS; Marto J; Iglehart DJ; Lazaro JB
Mol Cancer; 2011 Jun; 10():74. PubMed ID: 21679440
[TBL] [Abstract][Full Text] [Related]
3. WRN translocation from nucleolus to nucleoplasm is regulated by SIRT1 and required for DNA repair and the development of chemoresistance.
Lee SY; Lee H; Kim ES; Park S; Lee J; Ahn B
Mutat Res; 2015 Apr; 774():40-8. PubMed ID: 25801465
[TBL] [Abstract][Full Text] [Related]
4. Werner protein is a target of DNA-dependent protein kinase in vivo and in vitro, and its catalytic activities are regulated by phosphorylation.
Karmakar P; Piotrowski J; Brosh RM; Sommers JA; Miller SP; Cheng WH; Snowden CM; Ramsden DA; Bohr VA
J Biol Chem; 2002 May; 277(21):18291-302. PubMed ID: 11889123
[TBL] [Abstract][Full Text] [Related]
5. Serines 440 and 467 in the Werner syndrome protein are phosphorylated by DNA-PK and affects its dynamics in response to DNA double strand breaks.
Kusumoto-Matsuo R; Ghosh D; Karmakar P; May A; Ramsden D; Bohr VA
Aging (Albany NY); 2014 Jan; 6(1):70-81. PubMed ID: 24429382
[TBL] [Abstract][Full Text] [Related]
6. WRN counteracts the NHEJ pathway upon camptothecin exposure.
Otsuki M; Seki M; Kawabe Y; Inoue E; Dong YP; Abe T; Kato G; Yoshimura A; Tada S; Enomoto T
Biochem Biophys Res Commun; 2007 Apr; 355(2):477-82. PubMed ID: 17303082
[TBL] [Abstract][Full Text] [Related]
7. DNA damage modulates nucleolar interaction of the Werner protein with the AAA ATPase p97/VCP.
Partridge JJ; Lopreiato JO; Latterich M; Indig FE
Mol Biol Cell; 2003 Oct; 14(10):4221-9. PubMed ID: 12937274
[TBL] [Abstract][Full Text] [Related]
8. Human Ku autoantigen binds cisplatin-damaged DNA but fails to stimulate human DNA-activated protein kinase.
Turchi JJ; Henkels K
J Biol Chem; 1996 Jun; 271(23):13861-7. PubMed ID: 8662830
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-DNA adducts inhibit translocation of the Ku subunits of DNA-PK.
Turchi JJ; Henkels KM; Zhou Y
Nucleic Acids Res; 2000 Dec; 28(23):4634-41. PubMed ID: 11095672
[TBL] [Abstract][Full Text] [Related]
10. Interaction of FACT, SSRP1, and the high mobility group (HMG) domain of SSRP1 with DNA damaged by the anticancer drug cisplatin.
Yarnell AT; Oh S; Reinberg D; Lippard SJ
J Biol Chem; 2001 Jul; 276(28):25736-41. PubMed ID: 11344167
[TBL] [Abstract][Full Text] [Related]
11. Ku86 preserves chromatin integrity in cells adapted to high NaCl.
Dmitrieva NI; Celeste A; Nussenzweig A; Burg MB
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10730-5. PubMed ID: 16027367
[TBL] [Abstract][Full Text] [Related]
12. Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas.
Shao CJ; Fu J; Shi HL; Mu YG; Chen ZP
J Neurooncol; 2008 Aug; 89(1):27-35. PubMed ID: 18415044
[TBL] [Abstract][Full Text] [Related]
13. KU70/80, DNA-PKcs, and Artemis are essential for the rapid induction of apoptosis after massive DSB formation.
Abe T; Ishiai M; Hosono Y; Yoshimura A; Tada S; Adachi N; Koyama H; Takata M; Takeda S; Enomoto T; Seki M
Cell Signal; 2008 Nov; 20(11):1978-85. PubMed ID: 18674614
[TBL] [Abstract][Full Text] [Related]
14. DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner.
Zhang S; Schlott B; Görlach M; Grosse F
Nucleic Acids Res; 2004; 32(1):1-10. PubMed ID: 14704337
[TBL] [Abstract][Full Text] [Related]
15. The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunit.
Ader I; Muller C; Bonnet J; Favre G; Cohen-Jonathan E; Salles B; Toulas C
Oncogene; 2002 Sep; 21(42):6471-9. PubMed ID: 12226750
[TBL] [Abstract][Full Text] [Related]
16. Displacement of DNA-PKcs from DNA ends by the Werner syndrome protein.
Li B; Comai L
Nucleic Acids Res; 2002 Sep; 30(17):3653-61. PubMed ID: 12202749
[TBL] [Abstract][Full Text] [Related]
17. An antisense oligonucleotide targeted to human Ku86 messenger RNA sensitizes M059K malignant glioma cells to ionizing radiation, bleomycin, and etoposide but not DNA cross-linking agents.
Belenkov AI; Paiement JP; Panasci LC; Monia BP; Chow TY
Cancer Res; 2002 Oct; 62(20):5888-96. PubMed ID: 12384553
[TBL] [Abstract][Full Text] [Related]
18. WRN helicase accelerates the transcription of ribosomal RNA as a component of an RNA polymerase I-associated complex.
Shiratori M; Suzuki T; Itoh C; Goto M; Furuichi Y; Matsumoto T
Oncogene; 2002 Apr; 21(16):2447-54. PubMed ID: 11971179
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar localization of the human telomeric repeat binding factor 2 (TRF2).
Zhang S; Hemmerich P; Grosse F
J Cell Sci; 2004 Aug; 117(Pt 17):3935-45. PubMed ID: 15265990
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a glutathione S-transferase pi-activated prodrug in platinum-resistant ovarian cancer cells.
Townsend DM; Shen H; Staros AL; Gaté L; Tew KD
Mol Cancer Ther; 2002 Oct; 1(12):1089-95. PubMed ID: 12481432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
